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Abstract 
Background: The prevalence of allergy-related diseases (ARDs), including rhinitis, 
allergic conjunctivitis and eczema, is on the increase in Africa and globally. The causes 
of this increase are not well established. We set out to investigate the risk factors for 
ARDs among schoolchildren in Uganda.  
Methods: We conducted a secondary data analysis of a large asthma case-control 
study involving 1,700 schoolchildren, 5-17 years, in urban Uganda. ARDs were defined 
according to the International Study of Asthma and Allergies in Childhood (ISAAC) 
questionnaire. Skin prick testing (SPT) was conducted using standard procedures 
(seven allergen extracts) and allergen-specific IgE (asIgE) using ImmunoCAP® (three 
crude allergen extracts). We used inverse probability weighting to account for the 
differences in the sampling fractions in all our analyses. 
Results: The lifetime prevalence of reported rhinitis, allergic conjunctivitis and eczema 
was 43.3%, 39.5%, and 13.5%, respectively. There was overlap of ARDs, with 66.3% of 
1,193 schoolchildren who reported having ever an ARDs (including asthma) reporting 
two or more. The important risk factors for rhinitis ever were city residence at birth 
[adjusted odds ratio (95% confidence interval) 1.97 (1.26-3.10) compared to rural]; 
father’s [2.08 (1.57-2.75)] and mother’s history of allergic disease [2.29 (1.81-2.91)]; 
frequent de-worming in the last 12 months [1.80 (1.32-2.45), >2 versus none]; current 
high frequency of ‘trucks passing on the street near home’ [1.90 (1.19-3.03), ‘almost all 
the time’ versus rarely] and positive SPT [1.56 (1.24-1.96)] but not asIgE [1.33 (0.81-
2.18)]. The same pattern of risk factors was observed for allergic conjunctivitis and 
eczema.  
Conclusion: The transition from rural to urban environments and lifestyles is followed 
by an increase in all ARDs in Uganda. Additional research is required to identify specific 
exposures in early life that increase ARDs in urban areas, to inform intervention 
strategies for prevention in Africa and globally.  
  
Introduction 
Allergy-related diseases (ARDs) including rhinitis, allergic conjunctivitis and eczema are 
on the increase globally1, 2, but the causes of these diseases are generally not 
established3. These chronic recurrent conditions cause significant physical and 
psychological distress, sleep disturbance and reduced quality of life among people of all 
ages, but particularly among children3, 4. The worldwide prevalence is estimated as 42% 
for rhinitis2, 25% for allergic conjunctivitis4, and 8% for eczema5.  
In Africa, and other low and middle income countries (LMICs), the prevalence of these 
conditions is higher in urban than rural areas6-9. Although data on risk factors for ARDs 
from Africa is scarce, there is evidence to suggest that there may be important 
differences in risk factors between high income countries (HICs) and LMICs. For 
example, the International Study of Asthma and Allergies in Childhood (ISAAC) study 
reported a weaker association between ARDs and allergic sensitisation in LMICs than in 
HICs10. These differences were also supported by results from our own work on risk 
factors for asthma, another important ARD, among Ugandan schoolchildren11. Children 
born in rural areas had the lowest asthma risk, but this was not associated with 
exposure to farm animals in early life11 as has been found in Europe12, 13 and North 
America14, 15. Childhood asthma was also associated with a higher parental education 
and social-economic status11, in contrast to HICs where asthma is associated with low 
parental education and social economic status16, 17. Understanding the risk factors for 
ARDs in Africa is key to identifying the causes of these conditions and will inform local 
intervention strategies for prevention and treatment. We therefore undertook a 
secondary data analysis of a large asthma case-control study involving schoolchildren 
in urban Uganda, in order to investigate the risk factors for rhinitis, allergic conjunctivitis 
and eczema.  
 
Methods 
This was a secondary analysis of data from an asthma case-control study11. We report 
our findings according to the STROBE guidelines18. 
Study population and enrolment procedures 
Schoolchildren, 5-17 years, were enrolled from both primary and secondary schools in 
an urban area of Wakiso district in central Uganda between May 2015 and July 2017; 
further details of the study are described elsewhere11, 19. For each child with asthma 
(“cases”), two children without a history of asthma symptoms (“controls”) were randomly 
selected from the class register, using a random number generator programme in 
STATA (StataCorp, Texas, USA). The parents or guardians of potential participants 
were contacted to attend a meeting, using invitation cards delivered by the children or 
telephone calls by the study team. During the meeting, parents/guardians who were 
interested in having their children participate provided written informed consent. 
Children eight years or older provided written informed assent. 
The study was approved by the Uganda Virus Research Institute Research and Ethics 
Committee, and by the Uganda National Council for Science and Technology. 
Study procedures 
Data on rhinitis, allergic conjunctivitis and eczema were collected using the widely used 
and validated ISAAC questionnaire20, which was administered by the study team. 
Rhinitis was defined as ‘a problem with sneezing, or a runny, or a blocked nose when 
you did not have a cold or the flu’; allergic conjunctivitis was defined as ‘recurrent itchy-
watery eyes’; eczema was defined as ‘an itchy rash which was coming and going for at 
least 6 months, and in any of the following places: the folds of the elbows, behind the 
knees, in front of the ankles, under the buttocks, or around the neck, ears or eyes’. We 
included an additional question for urticarial rash which was defined as ‘itchy rash 
associated with wheals (ebilogologo - local terminology that is widely understood by the 
study population). Questions were answered by either the parents or the participant 
themselves (for adolescents). We used the ISAAC environmental questionnaire21 to 
collect data on risk factors for ARDs, and added questions relevant to this setting, such 
as residence at birth and in the first five years of life [rural or urban (small town or the 
city Kampala)], and frequency of de-worming in the last 12 months.  
We conducted assessments for allergic sensitisation. Skin prick testing (SPT) was 
conducted using standard procedures22 with seven crude allergen extracts 
[Dermatophagoides mix of D. farinae and D. pteronyssnus (dust mite), Blomia tropicalis 
(dust mite), Blattella germanica (cockroach), Arachis hypogaea (peanut), cat, pollen mix 
of weeds, mould mix of Aspergillus species; ALK Abello, Hoersholm, Denmark]. 
Fractional exhaled nitric oxide (FENO) was measured using a handheld device 
(NoBreath®, Bedfonf Scientific, Maidstone, United Kingdom). We used the 
manufacturer’s cut-off for children of >35 parts per billion. For allergen-specific IgE 
(asIgE), 200 aliquots of plasma were randomly selected from all participants for testing 
by ImmunoCAP® (Phadia, Uppsala, Sweden)23 using three crude allergen extracts (D. 
pteronyssinus, B. germanica and Arachis hypogaea). The standard cut-off for allergic 
sensitisation of >0.35 allergen-specific kilo units per litre (kUA/L) was used. Total IgE 
was also measured using ImmunoCAP®.   
Other assessments included the tuberculin skin test (TST) and stool examinations. TST 
was conducted using standard procedures we have described previously24. Examination 
for helminths was conducted on three stool samples freshly collected on different days, 
using the Kato Katz method25, and these included Schistosoma mansoni, Trichuris 
trichuria, hookworm, and Ascaris lumbricoides. 
Statistical considerations 
Data were collected on paper questionnaires and double data-entered into OpenClinica 
open source software version 3.1.4 (OpenClinica LLC and collaborators, Waltham, MA, 
USA). Cleaned data were transferred to STATA version 15 for analysis. Variables with 
clinically-relevant standard cut-off points, such as SPT, asIgE, FENO and TST, were 
analysed as binary variables. Total IgE was analysed as a continuous variable. The 
variable father’s and mother’s ‘history of allergic disease’ included a history of asthma, 
rhinitis, conjunctivitis, eczema and any other allergies such as urticaria. We used chi 
squared tests for comparison of the different risk factors among children with or without 
a given allergy-related condition.  
This was a secondary analysis of data from an asthma case-control study, and 
therefore it was not a random population sample. The population prevalence of asthma 
in urban Uganda is approximately 12%26, and our asthma case-control study enrolled all 
identified asthma cases in the population under study [in Wakiso District] and randomly 
selected twice the number of controls11. One might therefore expect that for every 100 
children in the source population, there would be 12 asthma cases and 24 non-
asthmatic controls (out of 88 non-asthmatics) selected. We therefore assumed that all 
cases in the source population were sampled, and that the sampling fraction in the non-
asthmatics was 24/88 (0.273). We therefore used inverse probability weighting to 
account for these sampling fractions in all our analyses, i.e. asthma cases received a 
weight of 1, whereas non-asthmatics received a weight of 3.67 (=1/0.273). 
We built each multiple logistic regression model by adding one confounder (identified in 
literature, and in preliminary analyses of the data) at a time and noted the change in 
effect side, we stopped adding when there was no change in effect size27. Variables that 
were strongly related (such as mother’s and father’s education, or area of residence at 
birth and area of residence in the first five years) were not included in the same model 
in order to minimize problems of collinearity27.  
In order to investigate whether the results on risk factors for rhinitis, allergic 
conjunctivitis and eczema were being driven by asthma, we conducted a sub-group 
analysis among schoolchildren with and without asthma separately, and obtained 
similar findings. We present results from the weighed analysis. 
 
Results 
For this analysis, we included all 1,700 schoolchildren enrolled in the asthma case-
control study; the detailed participant flow diagram has been published previously28. 
Prevalence of rhinitis, allergic conjunctivitis and eczema 
The lifetime prevalence of reported rhinitis, allergic conjunctivitis and eczema was 
43.3%, 39.5%, and 13.5%, respectively, while the prevalence in the last 12 months was 
10.1%, 9.1% and 2.3% respectively (Table 1). There was overlap of these ARDs (Table 
1); of the 1,193 schoolchildren who reported having ever had ARDs, 791 (66.3%) 
reported either two, three or four ARDs. The lifetime prevalence of urticarial rash and 
prevalence in the last 12 months was 31.9% and 1.8%, respectively (Table 1). The 
overall prevalence of positive skin prick test (to any of seven allergens) at enrolment 
was 34.7%.  
For the rest of the analysis, the main outcomes are the lifetime history of rhinitis, allergic 
conjunctivitis, and eczema because of larger numbers compared to the prevalence of 
these same conditions in the last 12 months.  
Risk factors for rhinitis 
Schoolchildren with a lifetime history of rhinitis were more likely to report a father’s 
[adjusted odds ratio (95% confidence interval), 2.08 (1.57-2.75)]; and mother’s history of 
allergic disease [2.29 (1.81-2.91)]; residing in the city at birth [1.97 (1.26-3.10)]; having 
a father with tertiary education [1.37 (1.03-1.80)]; the highest reported frequency of de-
worming in the last 12 months [1.80 (1.32-2.45)] and the highest reported frequency of 
‘trucks passing on the street near their home’ currently [1.90 (1.19-3.03)] than their 
counterparts without rhinitis (Table 2). They were more likely to have a positive skin 
prick test [1.56 (1.24-1.96)] and elevated FENO levels [2.06 (1.57-2.70)] than their 
counterparts without rhinitis, but there were no differences for asIgE and total IgE (Table 
2). They were less likely to have a positive tuberculin skin test at enrolment [0.66 (0.44-
1.01)] and had lower prevalence of helminths at enrolment [0.70 (0.50-0.97)] (Table 2). 
Similar results were observed for rhinitis in the last 12 months, albeit wider confidence 
intervals due to smaller numbers (Supplementary Table 1). 
Risk factors for allergic conjunctivitis 
Schoolchildren with a lifetime history of allergic conjunctivitis were more likely to report a 
father’s [2.06 (1.56-2.71)] and mother’s history of allergic disease [1.57 (1.24-1.98)]; 
residing in the city at birth [1.69 (1.09-2.64)]; report being exposed to farm animals in 
early life [1.33 (1.05-1.67)]; having a father with tertiary education [1.35 (1.03-1.79)]; the 
highest reported frequency of de-worming in last 12 months [1.94 (1.44-2.63)] and the 
highest reported frequency of ‘trucks passing on the street near their home’ currently 
[1.60 (1.03-2.48)] than their counterparts without allergic conjunctivitis (Table 3). They 
were more likely to have a positive SPT [1.76 (1.40-2.21)] and elevated FENO levels 
[1.57 (1.20-2.05)] than their counterparts without allergic conjunctivitis, but no difference 
for asIgE and total IgE (Table 3). Similar results were observed for allergic conjunctivitis 
in the last 12 months, albeit wider confidence intervals due to much smaller numbers. 
Risk factors for eczema  
Children with a lifetime history of eczema were more likely to report a father’s [2.19 
(1.56-3.09)] and mother’s history of allergic disease [1.94 (1.42-2.67)]; residing in the 
city at birth [1.55 (0.91-2.63)]; the highest reported frequency of de-worming in last 12 
months [1.63 (1.10-2.43)] and the highest reported frequency of ‘trucks passing on the 
street near their home’ currently [1.94 (1.14-3.32)] than their counterparts without 
eczema, but there were no differences for SPT, asIgE and total IgE (Table 4). Numbers 
for eczema in the last 12 months were small.  
Risk factors for ARDs combined 
Because of the high rate of multi-morbidity of ARDs (Table 1) and the high overlap of 
risk factors for these conditions (Tables 2-4), we created a new variable that combined 
all the ARDs (including asthma), and compared this to children who did not report any 
ARDs. We found the risk factors for any ARD ever to include a father’s [2.64 (1.89-
3.70)] and mother’s history of allergic disease [2.21 (1.70-2.86)]; city residence at birth 
[2.12 (1.26-3.57)]; exposure to farm animals in first five years of life [1.41 (1.11-1.80)]; 
the highest reported frequency of de-worming in the last 12 months [2.12 (1.51-2.99)] 
and ‘trucks passing on the street near home’ currently [2.18 (1.25-3.78)]; positive SPT 
[1.91 (1.49-2.46)] and elevated FENO [1.92 (1.40-2.64)], but not asIgE or total IgE 
(Table 5). These results were similar for ARDs in the last 12 months, except this time 
asIgE was statistically significant [1.85 (1.14-3.01)] (Supplementary Table 2). Similar 
results were observed for risk factors for ARDs among non-asthma controls only 
(Supplementary Table 3). 
Risk factors for positive skin prick test  
Children with positive SPT were more likely to report having a father [1.36 (1.02-1.81)] 
and/or a mother with tertiary education [1.72 (1.29-2.30)]; a father’s [1.41 (1.06-1.87)] 
and mother’s history of allergic disease [1.28 (1.00-1.63)]; residing in the city at birth 
[1.83 (1.17-2.86)]; the highest reported frequency of ‘trucks passing on the street near 
their home’ currently [2.26 (1.45-3.55)]; and were more likely to have elevated FENO 
[4.38 (3.29-5.82)], allergen-specific [25.91 (10.53-63.80)] and total IgE (Table 6). Similar 
results were observed in the sub-group analysis of only children without asthma. 
For urticarial rash, the statistically significant risk factors were a father’s and mother’s 
history of allergic disease, reported increased frequency of de-worming and of ‘trucks 
passing on the street near home’ in the last 12 months, but not SPT, asIgE and total IgE 
(Supplementary Table 4). 
Other potential factors, including maternal smoking during pregnancy (3%), current 
smoking by anyone in the household (including the child, 11%), and breastfeeding 




We found extensive multi-morbidity and substantial overlap of the risk factors for rhinitis, 
allergic conjunctivitis, eczema, urticarial rash and atopic sensitisation among 
schoolchildren in urban Uganda. The most consistent risk factors included parental 
history of allergic disease, city residence at birth, current proximity to a busy road, 
frequent de-worming, positive SPT and elevated FENO, but not allergen specific-IgE or 
total IgE to crude allergen extracts.  
We found that children born in the city (a proxy for mother’s residence during 
pregnancy) were at a higher risk of ARDs than their counterparts born in the village. 
This highlights the importance of exposures in early life and is consistent with the 
observation that the prevalence of ARDs is higher among children in urban than rural 
areas in Africa29 and other LMICs9. This observation is also consistent with studies from 
Europe and North America that report a lower risk of ARDs among children raised on 
farms (which are predominantly in rural areas), and this has been attributed to early life 
exposure to farm animals12, 30. On the contrary, we found a positive association between 
reported early life exposure to farm animals and ARDs. This implies that the observed 
‘protective rural effect’ in this setting could not be explained by exposure to farm 
animals, consistent with studies from other developing countries31, 32.  
We found a positive association between ARDs and positive SPT responses and with 
elevated FENO, which is consistent with underlying allergic inflammation that is 
common to these conditions3, 4. However, there was a lack of association between 
asIgE (to three crude allergen extracts) and rhinitis, conjunctivitis and eczema, despite 
the standard asIgE assessments and cut-off points used, and a strong association 
between asIgE and SPT reactivity. This lack of association may be explained, at least in 
part, by high levels of cross-reactive IgE to other environmental allergens, particularly to 
cross-reactive carbohydrate determinants, as reported by studies in Ghana33. Indeed, 
our recent work in Uganda shows that associations between asIgE or SPT sensitization 
and clinical allergy outcomes were weak among participants from the rural compared to 
the urban settings, and that rural residents a higher prevalence of helminths - an 
important source of environmental antigens34. Our observations are consistent with the 
ISAAC study, which reported a weaker association between ARDs and atopic 
sensitisation in LMICs than in HICs10. This weak/lack of association between ARDs and 
asIgE has important implications for diagnosis and treatment of these conditions in this 
setting: what proportion of these conditions are allergic, and would immunotherapy or 
biologicals treat as effectively as in HICs? This would require the use of component-
resolved diagnosis (using purified single protein allergens) to determine IgE 
sensitisation, with high cost implications that may be prohibitive, in this setting.  
The participant characteristics that were consistent across all ARDs was the reported 
high frequency of ‘trucks on the street near home’ and reported frequent use of de-
worming medication. We think ‘trucks near home’ is a proxy for proximity to a busy road, 
and this has been previously found to be positively associated with ARDs35, 36 and 
asthma morbidity37, and this is probably related to increased pollution. With regards to 
the reported increased frequency of deworming among children with the different ARDs 
including asthma11, we have no ready explanation. In Uganda, schoolchildren routinely 
receive mass drug administration with albendazole once a year, but in this study, 
children with ARDs were more likely to report being dewormed twice or more in the last 
one year, yet the prevalence of worm infections in this setting was low. The inverse 
association between rhinitis and the tuberculin skin test has been reported previously in 
South Africa38.  
A limitation of the study was that we performed standard tests for asIgE and total IgE on 
a randomly selected 400 schoolchildren, not the entire sample size of 1,700, limiting our 
power to detect weaker associations with rhinitis, conjunctivitis and eczema (we had 
good power to detect strong associations). The average age of the participants was 10 
years and as such, we could not obtain detailed information on some exposures in early 
life. Nevertheless, we highlight the importance of environmental exposures in early life 
in increasing the risk of ARDs in the urban setting. 
The strength of this study is the large sample size and the weighed analysis, which 
make our findings generalisable to schoolchildren in urban areas in Uganda, and 
probably in sub-Sahara Africa. The risk factors for rhinitis, conjunctivitis, eczema and 
atopic sensitisation (SPT) were similar to the risk factors for asthma reported in our 
earlier work11, even in the subgroup analysis of children without asthma. Given the 
similarity in risk factors, and the extensive overlap of these ARDs among children, it is 
possible that these conditions have the same underlying cause and as such, should be 
investigated as one entity in population studies. This hypothesis has also been 
suggested by other authors39, and is supported by studies that show the role of shared 
genetic and environmental factors40. The specific shared early life lifestyle and 
environmental risk factors have not been identified, but there are important differences 
with findings from HICs: in this setting, there is possibly a reduced role of asIgE and 
exposure to farm animals, an increased risk associated with higher parental education 
and socio-economic status41, and urbanisation7. Investigating these differences will 
increase our understanding of underlying causes of all allergy-related diseases. 
Conclusion 
The extensive multi-morbidity of, and overlap in the risk factors for, rhinitis, 
conjunctivitis, and eczema among schoolchildren in urban Uganda indicates the need to 
investigate these conditions as one entity in population studies. Our findings suggest 
that the transition from rural to urban environments and lifestyles is followed by an 
increase in all ARDs. More research is required to identify the specific exposures, 
particularly in early life, so as to inform local intervention strategies for prevention in 
Africa, which could be of global significance.  
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